Novo Nordisk files for US FDA regulatory approval of once-weekly semaglutide 2.4 mg for weight managementGlobeNewsWire • 12/04/20
EMISPHERE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Emisphere Technologies, Inc. - EMISBusiness Wire • 12/03/20
Novo Nordisk A/S (NVO) CEO Lars Jørgensen on ESG Conference Call - TranscriptSeeking Alpha • 11/30/20
Novo Nordisk, Trading Near Highs, Announces $1.8 Billion AcquisitionInvestors Business Daily • 11/06/20
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020GlobeNewsWire • 11/06/20
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 November 2020GlobeNewsWire • 11/05/20
Novo Nordisk A/S purchases B shares worth DKK 2,913 million from Novo Holdings A/S under the 2020 share repurchase programmeGlobeNewsWire • 11/03/20
Novo Nordisk A/S (NVO) CEO Lars Fruergaard Jorgensen on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/30/20
Novo Nordisk's operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates (CER) in the first nine months of 2020GlobeNewsWire • 10/30/20